home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Leukaemia Relapses Linked To DNA Repair Problems

  February, 7 2008 10:31
your information resource in human molecular genetics

Scientists have shown a link between acute myeloid leukaemia (AML), an aggressive cancer of the blood, and mutant genes in the DNA mismatch repair pathway. The study, to be published online in Cell Research, could lead to more successful approaches to treating patients with AML.

Most patients with AML achieve complete remission after chemotherapy but then undergo relapse. This relapse may be due to minimal residual disease, in which a small number of drug-resistant cells persist in the patient after achieving complete remission. The molecular basis for the resistance of some AMLs to chemotherapy, however, has so far remained unclear.

Liya Gu and colleagues looked at different stages of the disease to find that loss of DNA mismatch repair function is associated with relapsed AML and AML that is resistant to treatment, and that it may contribute to the development of the disease. The researchers have found that the phenotype of these drug-resistant cells is similar to cells that show loss of mismatch repair function. An understanding of how disrupted mismatch repair sensitizes cells to drug treatments should lead to more successful treatments for AML.

Author contact:

Liya Gu (University of Kentucky College of Medicine, Lexington, KY, USA)
E-mail: lgu0@email.uky.edu

For FREE original article, click here.

(C) Cell Research press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.